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Severe acute respiratory syndrome (SARS) was first
described during a 2002–2003 global outbreak of severe
pneumonia associated with human deaths and person-to-
person disease transmission. The etiologic agent was initial-
ly identified as a coronavirus by thin-section electron micro-
scopic examination of a virus isolate. Virions were spherical,
78 nm in mean diameter, and composed of a helical nucle-
ocapsid within an envelope with surface projections. We
show that infection with the SARS-associated coronavirus
resulted in distinct ultrastructural features: double-mem-
brane vesicles, nucleocapsid inclusions, and large granular
areas of cytoplasm. These three structures and the coron-
avirus particles were shown to be positive for viral proteins
and RNA by using ultrastructural immunogold and in situ
hybridization assays. In addition, ultrastructural examination
of a bronchiolar lavage specimen from a SARS patient
showed numerous coronavirus-infected cells with features
similar to those in infected culture cells. Electron microscop-
ic studies were critical in identifying the etiologic agent of the
SARS outbreak and in guiding subsequent laboratory and
epidemiologic investigations. 
A
large outbreak of severe pneumonia associated with
human deaths occurred in late 2002 in Guangdong
Province, China. Beginning in late February 2003, a simi-
lar illness was reported concurrently in Vietnam, Hong
Kong, Canada, Singapore, and other countries (1,2). The
disease, now known as severe acute respiratory syndrome
(SARS), causes an influenzalike illness with fever, cough,
dyspnea, and headache. Person-to-person transmission,
combined with international travel of infected persons,
accelerated the worldwide spread of the illness. By the
time the outbreak was contained, 8,098 probable cases,
resulting in 774 deaths, were identified in 29 countries (3).
A global network of 11 laboratories was established by
the World Health Organization to identify the causal agent
(4). Initial clinical and laboratory results focused on sever-
al known agents of respiratory illness, including human
metapneumovirus, influenza virus, and Chlamydia (4,5). A
virus was isolated from the oropharynx of a SARS patient
and identified by morphologic characteristics as belonging
to the family Coronaviridae (6–8); however, coronavirus-
es had not been a prime consideration in the differential
diagnosis since they rarely cause lower respiratory tract
infections in humans (9–11). Electron microscopic find-
ings thus shifted the focus of the laboratory investigation
toward verification of these observations. These findings
subsequently were corroborated by immunohistochemical,
immunofluorescent, and serologic assays, by additional
culture isolates, and by a variety of molecular approaches,
including reverse transcription–polymerase chain reaction,
microarray analysis, and sequencing (5–7,12,13). As a
result of those studies, the SARS-associated coronavirus
(SARS-CoV) is now recognized as the etiologic agent of
this syndrome.
We present here the ultrastructural features of SARS-
CoV in cell culture and in a bronchial alveolar lavage
(BAL) specimen. Viral immunogold labeling and ultra-
structural in situ hybridization (ISH) were used to further
analyze the morphogenesis of this newly emergent virus.
Methods
Infected and uninfected Vero E6 cells were harvested
3–5 days after inoculation, inactivated by fixation and
gamma irradiation (2 × 106 rad), and processed for stan-
dard, immunolabeling electron microscopy (IEM) or ISH
EM as previously described (6,14). For standard EM, glu-
taraldehyde- and osmium tetroxide–fixed specimens were
embedded in Epon-substitute and Araldite (Ted Pella, Inc.,
Redding, CA) and sections were stained with uranyl
acetate and lead citrate. Some infected and uninfected cul-
tures were treated with 5% tannic acid solution before
being embedded for standard EM (15). Specimens pre-
pared for IEM and ISH assays were fixed in paraformalde-
hyde and glutaraldehyde and embedded in LR White resin
(Ted Pella, Inc.), and sections were collected on nickel
mesh grids.
ABAL specimen was obtained from a 47-year-old man
within the first week of the onset of symptoms. A portion
of the specimen was centrifuged at 2,000 rpm for 10 min,
and the pellet was processed for standard EM. 
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USAIEM and ISH assays were performed essentially as
described for Nipah virus (14). In brief, for IEM assays,
sections were reacted with hyperimmune mouse ascitic
fluid raised against SARS-CoV and then with a goat anti-
mouse antibody conjugated to 12-nm colloidal gold parti-
cles (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Negative-sense riboprobes for the ultrastruc-
tural ISH assays were prepared as previously described
(16,17). Riboprobes were directed against the nucleocap-
sid or polymerase protein portions of the SARS-CoV
genome (Table) and incorporated digoxigenin-11-dUTP.
Because of the nested set structure of the coronavirus
genomic RNA(genRNA) and messenger RNAs (mRNAs),
the nucleocapsid riboprobe would detect all viral RNAs
(18). Sections were reacted with a pool of nucleocapsid
and polymerase probes and then with a sheep anti-digoxi-
genin antibody conjugated to 6-nm colloidal gold particles
(Electron Microscopy Sciences, Hatfield, PA). To obtain
negative controls, we performed both assays with uninfect-
ed Vero E6 cells, and infected cells were reacted with an
unrelated antibody and probe for IEM and ISH procedures,
respectively.
Results
Ultrastructural Characteristics of 
SARS-CoV–Infected Culture Cells
The morphologic features of SARS-CoV isolates were
similar to those of other members of the family
Coronaviridae. Multinucleated syncytial cells were occa-
sionally seen. Nascent particles were formed by the juxta-
position of viral nucleocapsids along cytoplasmic
membranes of the budding compartment (the membrane
region between the rough endoplasmic reticulum and the
Golgi complex) or occasionally on the membranes of the
rough endoplasmic reticulum that form the outer layer of
the nuclear membrane. Virions acquired an envelope by
budding into the cisternae and formed mostly spherical,
sometimes pleomorphic, particles that averaged 78 nm in
diameter (Figure 1A). Cross-sections through the helical
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Table. Riboprobes used for in situ hybridization studies of severe 
acute respiratory-syndrome-associated coronavirus
a 
Gene  Nucleotide positions  Riboprobe size (nucleotides) 
Polymerase  15,250–15,755  325 
Nucleocapsid  29,083–29,708  625 
aGenBank accession no. AY27874 
Figure 1. Assembly of severe acute respiratory syndrome–associated coronavirus (SARS-CoV)
particles in infected Vero E6 cells. A) Apposition of nucleocapsids (arrow) along membranes of the
budding compartment as particles developed and budded. Nucleocapsids measure 6 nm in diam-
eter and are mostly seen in cross-section. Some virions have an electron-lucent center, with the
nucleocapsid juxtaposed to the envelope, while others are relatively dark when the nucleocapsid
is present throughout the particle. Tannic acid pre-treatment enhance the visibility of the club-
shaped viral projections (inset), which average 14 nm in length. B) SARS-CoV–infected cell with
virus-containing vesicles, double-membrane vesicles (open arrow), and nucleocapsid inclusions
(arrowhead). Note the vesicle with granular material interspersed among the virions (arrow). C)
Higher magnification of a virus-containing vesicle with dark granular material. D) Tubular struc-
tures in a virus-containing vesicle. E) Virions in vesicles, which appeared to migrate toward and
fuse with the plasma membrane. The characteristic lining of particles along the cell surface is
seen. Bars: A, inset; B–D, 100 nm; E, 1 µm. NOTE: For full reproduction of these images, please
see http://www.cdc.gov/ncidod/ EID/vol10no2/03-0913.htmnucleocapsid were seen apposed to the viral envelope, and
the interior of the particles was usually electron-lucent.
Surface projections were faint in standard thin-section
preparations and could be better visualized by using a tan-
nic acid treatment (Figure 1A, inset).
Virus particles were seen in membrane-bound vesicles,
either as single particles or as groups in enlarged vesicles.
In some of these vesicles, dense, granular material was
seen interspersed between the virions (Figure 1B, C).
Tubular structures, averaging 20 nm in diameter, were seen
within some virion-containing vesicles (Figure 1D). The
vesicles appeared to migrate toward the cell surface and
fuse with the plasma membrane, releasing the viral parti-
cles (Figure 1E). Many of the particles adhered to the plas-
ma membrane, creating a knob-like appearance on the
surface of the cells.
Viral proteins and RNA were detected in virions by
IEM and ISH (Figure 2A,B), and in association with dou-
ble-membrane vesicles (Figure 3A,B), nucleocapsid inclu-
sions, and large granular areas of cytoplasm (Figure
4C,D). Double-membrane vesicles have been noted in
other coronavirus-infected cells (19,20) and consist of
cytoplasmic vesicles with two tightly apposed membranes
(Figure 1B). In contrast, double-membrane vesicles in
SARS-CoV–infected Vero E6 cells typically were com-
posed of accumulations of multiple single-membrane vesi-
cles enclosed within an outer membrane (Figure 3C), and
virus particles were sometimes located between the two
membranes (Figure 3D). Many double-membrane vesicles
contained diffuse, granular material. Cytoplasmic inclu-
sions of darkly staining viral nucleocapsids were mostly
found in association with virus-containing vesicles or dou-
ble-membrane vesicles (Figures 1B and 3D). Large, ill-
defined areas of cytoplasm, containing ribosomelike and
filamentous structures and devoid of other organelles,
were noted in some SARS-CoV–infected cells (Figure
4A,B). These areas strongly labeled for viral proteins and
RNA (Figure 4C,D), with IEM and ultrastructural ISH
assays. No antigens or RNA were detected by reacting
hyperimmune mouse ascitic fluid or riboprobes with
uninfected Vero E6 cells or by reacting an unrelated hyper-
immune mouse ascitic fluid or riboprobe with SARS-
CoV–infected cells.
Finally, as has been reported previously for other coro-
naviruses, SARS-CoV–infected cells also contained tubu-
loreticular structures, with virions sometimes forming
along the membranes (Figure 3C). The tubuloreticular
structures were often found in close association with dou-
ble-membrane vesicles.
Ultrastructural Characteristics of 
SARS-CoV–Infected BAL Specimen
Anumber of coronavirus-infected cells were seen with-
in a BAL specimen from a SARS patient (Figure 5A,B).
Virus particles budded into, and were associated with,
vesicles, and extracellular virions covered the exterior sur-
face of the cells. Areas of double-membrane vesicles con-
taining a diffuse granular material were also seen. 
Discussion
During the global SARS outbreak of 2002 to 2003, a
virus was isolated from human patients and identified by
EM as belonging to the family Coronaviridae (6,7).
Detailed studies described here on the morphogenesis of
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Figure 2. Detection of viral proteins and viral RNA associated with intracytoplasmic virions. A) Immunogold labeling of viral proteins by
using hyperimmune mouse ascitic fluid directed against severe acute respiratory syndrome–associated coronavirus (12 nm gold). B)
Ultrastructural in situ hybridization detection of viral RNA by using a pool of polymerase and nucleocapsid riboprobes (6 nm gold). Bars,
100 nm.NOTE: For full reproduction of these images, please see http://www.cdc.gov/ncidod/EID/vol10no2/03-0913.htmthe SARS-CoV by thin-section EM found many character-
istics previously described for coronaviruses (19,21,22).
Virus particles formed upon membranes of the “budding
compartment,” a term used to describe the continuous
membrane system from the rough endoplasmic reticulum
to the Golgi complex (23,24). Virions accumulated in
dilated vesicles that appeared to migrate to the cell surface
where the virus particles were released or remained adher-
ent to the plasma membrane. Additional cytoplasmic struc-
tures associated with coronavirus infections included
nucleocapsid inclusions and double-membrane vesicles,
which have been proposed as the replication complex for
coronaviruses (20) and arteriviruses (25), a closely related
virus family that, in addition to coronaviruses, is a member
of the order Nidovirales. IEM and ultrastructural ISH
assays detected viral proteins and mRNAor genRNAasso-
ciated with virions, double-membrane vesicles, and nucle-
ocapsid inclusions. Coronaviruses are known to synthesize
a nested set of subgenomic mRNAs (26), such that the
nucleocapsid riboprobe used here allowed detection of all
viral mRNAs in addition to genRNA. Indeed, considerable
amounts of RNAs were detected in the ultrastructural ISH
assays performed on SARS-CoV–infected cells. 
As has been reported for other coronaviruses, addition-
al cytoplasmic features were associated with SARS-
CoV–infected cells. Tubular structures were occasionally
seen within virus-containing vesicles (27,28); and cyto-
plasmic tubuloreticular structures, known to occur with
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Figure 3. Ultrastructural characteristics of double-membrane
vesicles. A) Immunogold labeling of viral proteins by using
hyperimmune mouse ascitic fluid (12 nm gold) in areas of cyto-
plasm in close proximity to the double-membrane vesicles. B)
Ultrastructural in situ hybridization detection of viral mRNA,
genRNA, or both (6 nm gold) in the same areas and also at
times associated with diffuse granular material within the dou-
ble-membrane vesicles. C) Double-membrane vesicles show-
ing several single-membrane vesicles enclosed within an outer
membrane (arrowhead). Also present is a tubuloreticular struc-
ture (arrow) with virus particles budding from the membranes.
D) Double-membrane vesicles with a large space between the
inner (arrow) and outer (open arrow) membranes of the vesi-
cles. Virions are seen budding into (arrowheads) and accumu-
lating within the dilated inter-membrane space. At the periphery
of the double-membrane vesicles are nucleocapsid inclusions;
arrows point to discernable nucleocapsids (small arrows). Bars,
100 nm. NOTE: For full reproduction of these images, please
see http://www.cdc.gov/ncidod/EID/vol10no2/03-0913.htmnumerous other infections (29), were also found. Large
granular areas of cytoplasm, relatively devoid of
organelles and containing viral proteins and RNA, were
noted in SARS-CoV–infected cells; such features have not
been described previously for coronaviruses. While the
role of these cytoplasmic areas is unclear, the close prox-
imity of cellular ribosomes with viral proteins and RNA
suggests that they may be viral translation centers. Future
ultrastructural ISH and IEM studies to characterize these
areas, using riboprobes and monoclonal antibodies to spe-
cific SARS-CoV genes and gene products, should help
clarify this issue.
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Figure 4. Immunogold and in situ hybridization
(ISH) labeling of severe acute respiratory syn-
drome–associated coronavirus–infected cells. A)
Cytoplasmic area that is relatively free of
organelles (arrow). B) At higher magnification,
these regions are shown to consist of ribosomelike
and filamentous structures. Within these regions,
C) viral proteins are detected by immunolabeling,
using hyperimmune mouse ascitic fluid (12 nm
gold), and D) ultrastructural ISH detects viral
mRNA, genRNA, or both, by using a pool of ribo-
probes (6 nm gold). Bars, A,1 mm; B–D, 100 nm.
NOTE: For full reproduction of these images,
please see http://www.cdc.gov/ncidod/EID/
vol10no2/03-0913.htm
A
Figure 5. Ultrastructural characteristics
of a bronchial alveolar lavage (BAL)
from a patient with severe acute respi-
ratory syndrome. A) Infected cells
showing numerous cytoplasmic and
extracellular virions (arrowheads). Note
the region of double-membrane vesi-
cles (arrow), a common feature of coro-
navirus-infected cells. B) At higher
magnification, double-membrane vesi-
cles (arrow) are shown to contain dif-
fuse, granular material. Bars, 1 µm.
NOTE: For full reproduction of these
images, please see http://www.cdc.
gov/ncidod/EID/ vol10no2/03-0913.htmMany of these ultrastructural findings were also
observed in a BALspecimen from a SARS patient (Figure
5B) (6). Characteristic virions in vesicles and lining the
cell surface and the presence of double-membrane vesi-
cles provided clear evidence of a coronavirus infection
and suggested that viral replication was occurring in the
lower airways early in the course of infection. EM exam-
ination of BAL specimens may prove to be a useful tool
in the diagnosis of SARS-CoV, analogous to the use of
BAL specimens to diagnose influenza infections. Recent
studies have reported finding coronavirus particles in lung
and gastroenteric tissues of SARS patients and experi-
mentally infected macaques (7,30–33), although the viral
nature of these structures has not been confirmed by IEM
or ultrastructural ISH assays. Coronavirus particles may
be      confused morphologically with other nonviral struc-
tures routinely found in cells, including coated vesicles,
multivesicular bodies, perichromatin granules, glycoca-
lyceal bodies, and cellular projections (see 29). Therefore,
a cautious approach is advisable when examining clinical
specimens.
The SARS outbreak is a prime example of an emerging
infectious disease that can rapidly and easily spread, reach-
ing global proportions. With SARS, as with previous
investigations of outbreaks involving such viruses as
Ebola (34–36), Hendra (37), Nipah (38), and more recent-
ly, monkeypox (39), EM played an essential role in deter-
mining the specific virus family of the pathogen involved.
In all of these cases, tissue culture amplification of a virus
isolate facilitated the ultrastructural examination. Thus,
traditional microbiologic and EM approaches proved piv-
otal in determining the etiologic agents, thereby guiding
subsequent laboratory and epidemiologic investigations.
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